Michael Vasconcelles

Director; Head of Research and Dev. · 4 filings · Latest: Jun 4, 2026

Day One Biopharmaceuticals, Inc.

Kura Oncology, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
DAWN	Michael Vasconcelles	Head of Research and Dev.	Feb 17, 2026	Sale	$11.60	2,728	$31.6K	4,397	Feb 18 10:13 PM
DAWN	Michael Vasconcelles	Head of Research and Dev.	Feb 15, 2026	Option Exercise	—	7,125	—	7,125	Feb 18 10:13 PM